CWM
BCRX icon

CIBC World Markets’s BioCryst Pharmaceuticals BCRX Stock Holding History

CIBC World Markets’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$108K Buy
+13,858
New +$100K ﹤0.01% 1170
2025
Q2 		$231K Sell
25,810
-20,040
-44% -$187K ﹤0.01% 1215
2025
Q1 		$344K Buy
45,850
+26,512
+137% +$214K ﹤0.01% 1198
2024
Q4 		$145K Buy
+19,338
New +$147K ﹤0.01% 1171

Other funds holding BCRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CIBC World Markets's BCRX Position: Q4 2025 in Review

CIBC World Markets opened a new position in BioCryst Pharmaceuticals (BCRX) in Q4 2025: 13,858 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #1170 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in BCRX as recently as Q2 2025.

CIBC World Markets first reported a position in BCRX in Q4 2024 and has held it in 4 quarters since. The position peaked at $344K in Q1 2025. 272 funds tracked by Wall St. Rank hold BCRX as of Q4 2025.

  • CIBC World Markets held 13,858 shares of BioCryst Pharmaceuticals worth $108K as of Q4 2025.
  • BioCryst Pharmaceuticals was a new CIBC World Markets position in Q4 2025.
  • BioCryst Pharmaceuticals made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1170 holding.
  • CIBC World Markets first reported a position in BioCryst Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's BioCryst Pharmaceuticals position peaked at $344K in Q1 2025.
  • 272 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.